Share Twitter LinkedIn Facebook Email Rafael G Amado, MD, Adaptimmune, LLC, Hopes T-cell Therapies Will Lead to Approval Difficult to treat solid tumors with adoptive T-cell at Annual Meeting 2018.
Exploring Cabozantinib Plus Nivolumab: A Breakthrough in Advanced Angiosarcoma – An Interview with Dr. Gary Schwartz Sarcoma 1 Min Read